Tejnaksh Healthcare Intrinsic Value
TEJNAKSH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹7.20 | ₹5.76 - ₹8.64 | -54.6% | EPS: ₹0.60, Sector P/E: 12x |
| Book Value Method | asset | ₹27.00 | ₹24.30 - ₹29.70 | +70.3% | Book Value/Share: ₹27.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹9.60 | ₹8.64 - ₹10.56 | -39.4% | Revenue/Share: ₹12.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹21.90 | ₹19.71 - ₹24.09 | +38.2% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹39.62 | ₹31.70 - ₹47.54 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹4.75 | ₹4.28 - ₹5.23 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹4.94 | ₹4.45 - ₹5.43 | -68.8% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹19.09 | ₹17.18 - ₹21.00 | +20.4% | EPS: ₹0.60, BVPS: ₹27.00 |
Want to compare with current market value? Check TEJNAKSH share price latest .
Valuation Comparison Chart
TEJNAKSH Intrinsic Value Analysis
What is the intrinsic value of TEJNAKSH?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Tejnaksh Healthcare (TEJNAKSH) is ₹19.09 (median value). With the current market price of ₹15.85, this represents a +20.4% variance from our estimated fair value.
The valuation range spans from ₹4.75 to ₹39.62, indicating ₹4.75 - ₹39.62.
Is TEJNAKSH undervalued or overvalued?
Based on our multi-method analysis, Tejnaksh Healthcare (TEJNAKSH) appears to be trading below calculated value by approximately 20.4%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.11 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Operating Margin | 26.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.40x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Tejnaksh Healthcare
Additional stock information and data for TEJNAKSH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |